ScoreWhy is Sequent Scientific Ltd ?
1
Weak Long Term Fundamental Strength with a -3.55% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 8.15 times
- The company has been able to generate a Return on Equity (avg) of 3.90% signifying low profitability per unit of shareholders funds
2
With a growth in Net Profit of 209.15%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 7 consecutive quarters
- PBT LESS OI(Q) At Rs 26.71 cr has Grown at 246.43%
- PAT(Q) At Rs 15.97 cr has Grown at 162.7%
- ROCE(HY) Highest at 10.65%
3
With ROCE of 10.2, it has a Fair valuation with a 4.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 0.46%, its profits have risen by 128.2% ; the PEG ratio of the company is 0.9
4
Majority shareholders : Promoters
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sequent Scien. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sequent Scien. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sequent Scien.
0.14%
0.00
46.70%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.42%
EBIT Growth (5y)
-3.55%
EBIT to Interest (avg)
1.94
Debt to EBITDA (avg)
9.96
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
1.28
Tax Ratio
29.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.82%
ROCE (avg)
5.29%
ROE (avg)
3.90%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
114
Industry P/E
34
Price to Book Value
6.26
EV to EBIT
43.93
EV to EBITDA
29.09
EV to Capital Employed
4.47
EV to Sales
3.31
PEG Ratio
0.91
Dividend Yield
NA
ROCE (Latest)
10.17%
ROE (Latest)
5.48%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
PBT LESS OI(Q)
At Rs 26.71 cr has Grown at 246.43%
PAT(Q)
At Rs 15.97 cr has Grown at 162.7%
ROCE(HY)
Highest at 10.65%
OPERATING PROFIT TO INTEREST(Q)
Highest at 4.12 times
DEBT-EQUITY RATIO(HY)
Lowest at 0.61 times
PBDIT(Q)
Highest at Rs 55.68 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 13.13%
EPS(Q)
Highest at Rs 0.59
-3What is not working for the Company
DPS(Y)
Lowest at Rs 0.00
DPR(Y)
Lowest at 0.00%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.92 times
Loading Valuation Snapshot...
Here's what is working for Sequent Scien.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 26.71 cr has Grown at 246.43%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 15.97 cr has Grown at 162.7%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 4.12 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Profit (PBDIT) - Quarterly
Highest at Rs 55.68 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 13.13%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 26.71 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 15.97 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.59
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Lowest at 0.61 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Sequent Scien.
Debtors Turnover Ratio- Half Yearly
Lowest at 3.92 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Dividend per Share (DPS) - Annually
Lowest at Rs 0.00
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (Rs)
Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
